Table 1. Diagnostic, epidemiologic, and molecular data for persons with symptoms of pneumonic plague during pneumonic plague outbreak, northern Madagascar, 2011*.
| Patient/household | Received antimicrobial drug treatment and survived | Sampling | RDT | Serologic analysis | Culture | WHO case definition | Molecular analysis |
|---|---|---|---|---|---|---|---|
| 1/A | No | No | ND | ND | ND | Suspected | ND |
| 2/A | No | No | ND | ND | ND | Suspected | ND |
| 3/A | No | No | ND | ND | ND | Suspected | ND |
| 4/A | No | No | ND | ND | ND | Suspected | ND |
| 5/A | No | No | ND | ND | ND | Suspected | ND |
| 6/A | No | No | ND | ND | ND | Suspected | ND |
| 7/A | No | No | ND | ND | ND | Suspected | ND |
| 8/B | No | No | ND | ND | ND | Suspected | ND |
| 9/C | No | No | ND | ND | ND | Suspected | ND |
| 10/B | No | No | ND | ND | ND | Suspected | ND |
| 11/B | No | No | ND | ND | ND | Suspected | ND |
| 12/A | Yes | Serum/sputum | + | +† | – | Confirmed | + |
| 13/A | Yes | Serum/sputum | + | +† | – | Confirmed | + |
| 14/B | No | No | ND | ND | ND | Suspected | ND |
| 15/D | Yes | Serum | ND | – | ND | Suspected | ND |
| 16/A | Yes | Serum | ND | – | ND | Suspected | ND |
| 17/B | Yes | Serum | ND | +† | ND | Confirmed | ND |
| 18/E | No | No | ND | ND | ND | Suspected | ND |
| 19/E | No | No | ND | ND | ND | Suspected | ND |
| 20/F | No | No | ND | ND | ND | Suspected | ND |
*RDT, rapid dipstick test; WHO, World Health Organization; ND, not done; +, positive; –, negative. †A 4-fold increase in titer in the second serum sample.